The Normal anticoagulant system and risk of placental abruption: Protein C, protein S and resistance to activated protein C

Cande V. Ananth, Carl A. Nath, Claire Philipp

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective. To examine the association between maternal thrombophilia associated with anticoagulation (proteins C and S and activated protein C resistance ratio, APCR) and risk of placental abruption. Methods.Data were derived from a casecontrol study The New Jersey-Placental Abruption Study (20022007). Maternal blood was collected from abruption cases and controls and was assayed for the thrombophilias. Decreased protein C, S and APCR was defined as values<5 and<10 among controls. Results.Of a total of 132 cases and 127 controls, 3 were heterozygous for the factor V Leiden mutation (1 case and 2 controls). Mean (± standard deviation) protein C (114.2±25.6 vs. 121.4±27.6; p=0.009), protein S (39.9±18.4 vs. 35.7±15.2; p=0.043) and APCR (2.86±0.29 vs. 2.88±0.27; p=0.039) were different between cases and controls. Abruption cases were associated with an odds ratio of 3.2 (95 CI 1.2, 9.9) in relation to decreased protein C (<Fifth centile). Decreases in both protein S and APCR ratio were not associated with abruption. Conclusions.A decrease in protein C was associated with an increased risk for abruption, suggesting an important role for the physiologic anticoagulant system in the etiology of placental abruption.

Original languageEnglish (US)
Pages (from-to)1377-1383
Number of pages7
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume23
Issue number12
DOIs
StatePublished - Dec 1 2010

Fingerprint

Activated Protein C Resistance
Pregnancy Proteins
Abruptio Placentae
Protein S
Protein C
Anticoagulants
Odds Ratio
Mothers
Thrombophilia
Mutation

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Keywords

  • Thrombophilia
  • activated protein C resistance
  • placental abruption
  • protein C
  • protein S

Cite this

@article{b3e982879b244426bf76db7444e914b9,
title = "The Normal anticoagulant system and risk of placental abruption: Protein C, protein S and resistance to activated protein C",
abstract = "Objective. To examine the association between maternal thrombophilia associated with anticoagulation (proteins C and S and activated protein C resistance ratio, APCR) and risk of placental abruption. Methods.Data were derived from a casecontrol study The New Jersey-Placental Abruption Study (20022007). Maternal blood was collected from abruption cases and controls and was assayed for the thrombophilias. Decreased protein C, S and APCR was defined as values<5 and<10 among controls. Results.Of a total of 132 cases and 127 controls, 3 were heterozygous for the factor V Leiden mutation (1 case and 2 controls). Mean (± standard deviation) protein C (114.2±25.6 vs. 121.4±27.6; p=0.009), protein S (39.9±18.4 vs. 35.7±15.2; p=0.043) and APCR (2.86±0.29 vs. 2.88±0.27; p=0.039) were different between cases and controls. Abruption cases were associated with an odds ratio of 3.2 (95 CI 1.2, 9.9) in relation to decreased protein C (<Fifth centile). Decreases in both protein S and APCR ratio were not associated with abruption. Conclusions.A decrease in protein C was associated with an increased risk for abruption, suggesting an important role for the physiologic anticoagulant system in the etiology of placental abruption.",
keywords = "Thrombophilia, activated protein C resistance, placental abruption, protein C, protein S",
author = "Ananth, {Cande V.} and Nath, {Carl A.} and Claire Philipp",
year = "2010",
month = "12",
day = "1",
doi = "10.3109/14767051003710284",
language = "English (US)",
volume = "23",
pages = "1377--1383",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "12",

}

The Normal anticoagulant system and risk of placental abruption : Protein C, protein S and resistance to activated protein C. / Ananth, Cande V.; Nath, Carl A.; Philipp, Claire.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 23, No. 12, 01.12.2010, p. 1377-1383.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The Normal anticoagulant system and risk of placental abruption

T2 - Protein C, protein S and resistance to activated protein C

AU - Ananth, Cande V.

AU - Nath, Carl A.

AU - Philipp, Claire

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Objective. To examine the association between maternal thrombophilia associated with anticoagulation (proteins C and S and activated protein C resistance ratio, APCR) and risk of placental abruption. Methods.Data were derived from a casecontrol study The New Jersey-Placental Abruption Study (20022007). Maternal blood was collected from abruption cases and controls and was assayed for the thrombophilias. Decreased protein C, S and APCR was defined as values<5 and<10 among controls. Results.Of a total of 132 cases and 127 controls, 3 were heterozygous for the factor V Leiden mutation (1 case and 2 controls). Mean (± standard deviation) protein C (114.2±25.6 vs. 121.4±27.6; p=0.009), protein S (39.9±18.4 vs. 35.7±15.2; p=0.043) and APCR (2.86±0.29 vs. 2.88±0.27; p=0.039) were different between cases and controls. Abruption cases were associated with an odds ratio of 3.2 (95 CI 1.2, 9.9) in relation to decreased protein C (<Fifth centile). Decreases in both protein S and APCR ratio were not associated with abruption. Conclusions.A decrease in protein C was associated with an increased risk for abruption, suggesting an important role for the physiologic anticoagulant system in the etiology of placental abruption.

AB - Objective. To examine the association between maternal thrombophilia associated with anticoagulation (proteins C and S and activated protein C resistance ratio, APCR) and risk of placental abruption. Methods.Data were derived from a casecontrol study The New Jersey-Placental Abruption Study (20022007). Maternal blood was collected from abruption cases and controls and was assayed for the thrombophilias. Decreased protein C, S and APCR was defined as values<5 and<10 among controls. Results.Of a total of 132 cases and 127 controls, 3 were heterozygous for the factor V Leiden mutation (1 case and 2 controls). Mean (± standard deviation) protein C (114.2±25.6 vs. 121.4±27.6; p=0.009), protein S (39.9±18.4 vs. 35.7±15.2; p=0.043) and APCR (2.86±0.29 vs. 2.88±0.27; p=0.039) were different between cases and controls. Abruption cases were associated with an odds ratio of 3.2 (95 CI 1.2, 9.9) in relation to decreased protein C (<Fifth centile). Decreases in both protein S and APCR ratio were not associated with abruption. Conclusions.A decrease in protein C was associated with an increased risk for abruption, suggesting an important role for the physiologic anticoagulant system in the etiology of placental abruption.

KW - Thrombophilia

KW - activated protein C resistance

KW - placental abruption

KW - protein C

KW - protein S

UR - http://www.scopus.com/inward/record.url?scp=78249262582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78249262582&partnerID=8YFLogxK

U2 - 10.3109/14767051003710284

DO - 10.3109/14767051003710284

M3 - Article

C2 - 20334530

AN - SCOPUS:78249262582

VL - 23

SP - 1377

EP - 1383

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 12

ER -